The Efficacy of Medical Marijuana: Health Benefits and Patient Experiences

Your name ENGL 1000 Professor Jessup July 24, 2025 Outline I. Introduction * Contextualizes chronic pain and its toll on quality of life and opioid use. * Introduces medical marijuana as an emerging therapeutic option. * States the paper's focus: examining evidence for cannabis in pain relief, opioid reduction, and safety considerations. II. Efficacy in Pain Relief and Quality of Life * Reviews clinical trials showing modest pain relief benefits. * Highlights observational and patient-reported data showing broader symptom relief (e.g., anxiety, insomnia). * Emphasizes cannabis as a conditional or secondary treatment option. III. Potential Opioid-Sparing Effects * Discusses limited and low-certainty evidence from systematic reviews. * Presents observational studies where patients reduced opioid use after starting medical cannabis. * Notes inability to establish causation but recognizes meaningful patient-reported experiences. IV. Formulation, Patient Selection, and Safety Considerations * Details the benefits of non-inhaled, controlled THC/CBD preparations. * Notes inconsistencies in dosage and delivery methods across studies. * Lists common short-term side effects and emerging concerns (e.g., hyperemesis, cognitive risks). * Emphasizes the need for careful patient selection and monitoring. V. Discussion * Synthesizes clinical vs. real-world findings: modest trial outcomes vs. stronger patient-reported benefits. * Positions medical cannabis as a complementary, not primary, treatment for chronic and neuropathic pain. VI. Conclusion and Future Questions * Affirms the therapeutic potential of cannabis in specific contexts. * Stresses the need for further research on standardized dosing and long-term effects. * Calls for future clinical trials to address safety and cognitive risks. The Efficacy of Medical Marijuana: Health Benefits and Patient Experiences Chronic pain is a significant burden to the global healthcare system and, in most cases, has been known to lead to poor quality of life and dependency on opioids, which is quite hazardous in terms of healthcare. Through the growing popularity of alternative medicine, medical marijuana, especially in non-smoking form, has become a therapeutic and controversial topic. In the current paper, available evidence on the potential of medical cannabis to improve pain, sleep, and health-related quality of life and the consequences of its potential to reduce the use of opioids are evaluated, and questions concerning its safety are discussed. It reveals that medical cannabis can be instrumental in the treatment of the selected patients under certain circumstances, albeit it may be the case that minor ones are being offered. Efficacy in Pain Relief and Quality of Life According to a BMJ systematic review and a meta-analysis of the randomized trials published in the year 2021, compared to placebo, non-inhaled cannabis or cannabinoid preparations resulted in small to minimal benefits in chronic non-cancer pain with moderate certainty of evidence (Wang et al. n1034). These results were confirmed by the 2024 Agency for Healthcare Research and Quality (AHRQ) livin...